// App-Quantinova.ai

877 : Fitusiran Treatment Impacts on Health-Related Quality of Life in Subjects with Hemophilia A and B with Inhibitors Assessed with the Haemophilia Quality of Life Questionnaire for Adults (Haem-A-QoL)

Researchers

Presenter

  • Sylvia Von Mackensen

Principal Investigators

  • Pratima Chowdary

  • Sarah Mangles

  • Qifeng Yu

  • Baisong Mei

  • Shauna R. Andersson

  • Pronabesh Dasmahapatra

Medical Centers

  • Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free NHS Trust, London, United Kingdom

  • Haemophilia, Haemostasis and Thrombosis Centre, Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom

  • Sanofi, Cambridge, MA

Locations

  • Germany

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Open Label

  • Dose Escalation

  • Cohort

Phase

  • II

Study Id's

  • NCT02035605

  • NCT02554773

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved